These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
330 related articles for article (PubMed ID: 32376430)
21. Alopecia areata exhibits cutaneous and systemic OX40 activation across atopic backgrounds. Kim M; Del Duca E; Dahabreh D; Lozano-Ojalvo D; Carroll B; Manson M; Bose S; Gour D; NandyMazumdar M; Liu Y; Yu Ekey M; Chowdhury A; Angelov M; Ungar B; Estrada Y; Guttman-Yassky E Allergy; 2024 Aug; ():. PubMed ID: 39115359 [TBL] [Abstract][Full Text] [Related]
22. Cross-Sectional Study of Psoriasis, Atopic Dermatitis, Rosacea, and Alopecia Areata Suggests Association With Cardiovascular Diseases. Pagan AD; Jung S; Caldas S; Ungar J; Gulati N; Ungar B J Drugs Dermatol; 2023 Jun; 22(6):576-581. PubMed ID: 37276159 [TBL] [Abstract][Full Text] [Related]
23. Health-related quality of life (HRQoL) among patients with alopecia areata (AA): A systematic review. Liu LY; King BA; Craiglow BG J Am Acad Dermatol; 2016 Oct; 75(4):806-812.e3. PubMed ID: 27436156 [TBL] [Abstract][Full Text] [Related]
24. CCL13 is upregulated in alopecia areata lesions and is correlated with disease severity. Wang D; Xu X; Li X; Shi J; Tong X; Chen J; Lu J; Huang J; Yang S Exp Dermatol; 2021 May; 30(5):723-732. PubMed ID: 33523560 [TBL] [Abstract][Full Text] [Related]
25. T-helper and regulatory T-cell cytokines in the peripheral blood of patients with active alopecia areata. Tembhre MK; Sharma VK Br J Dermatol; 2013 Sep; 169(3):543-8. PubMed ID: 23607748 [TBL] [Abstract][Full Text] [Related]
26. Understanding the significance of cytokines and chemokines in the pathogenesis of alopecia areata. Ito T; Kageyama R; Nakazawa S; Honda T Exp Dermatol; 2020 Aug; 29(8):726-732. PubMed ID: 32533873 [TBL] [Abstract][Full Text] [Related]
27. Dissecting susceptibility from exogenous triggers: the model of alopecia areata and associated inflammatory skin diseases. Garzorz N; Alsisi M; Todorova A; Atenhan A; Thomas J; Lauffer F; Ring J; Schmidt-Weber C; Biedermann T; Eyerich S; Eyerich K J Eur Acad Dermatol Venereol; 2015 Dec; 29(12):2429-35. PubMed ID: 26416203 [TBL] [Abstract][Full Text] [Related]
28. Exploring Immune Development in Infants With Moderate to Severe Atopic Dermatitis. Hulshof L; Overbeek SA; Wyllie AL; Chu MLJN; Bogaert D; de Jager W; Knippels LMJ; Sanders EAM; van Aalderen WMC; Garssen J; Van't Land B; Sprikkelman AB; Front Immunol; 2018; 9():630. PubMed ID: 29966024 [TBL] [Abstract][Full Text] [Related]
29. Alopecia areata and overt thyroid diseases: A nationwide population-based study. Han TY; Lee JH; Noh TK; Choi MW; Yun JS; Lee KH; Bae JM J Dermatol; 2018 Dec; 45(12):1411-1417. PubMed ID: 30222206 [TBL] [Abstract][Full Text] [Related]
30. Scalp biomarkers during dupilumab treatment support Th2 pathway pathogenicity in alopecia areata. Renert-Yuval Y; Pavel AB; Del Duca E; Facheris P; Pagan AD; Bose S; Gómez-Arias PJ; Angelov M; Bares J; Chima M; Estrada YD; Garcet S; Lebwohl MG; Krueger JG; Guttman-Yassky E Allergy; 2023 Apr; 78(4):1047-1059. PubMed ID: 36271804 [TBL] [Abstract][Full Text] [Related]
33. Tape-Strip Proteomic Profiling of Atopic Dermatitis on Dupilumab Identifies Minimally Invasive Biomarkers. He H; Olesen CM; Pavel AB; Clausen ML; Wu J; Estrada Y; Zhang N; Agner T; Guttman-Yassky E Front Immunol; 2020; 11():1768. PubMed ID: 32849633 [TBL] [Abstract][Full Text] [Related]
34. Imbalance of T-helper 17 and regulatory T cells in patients with alopecia areata. Han YM; Sheng YY; Xu F; Qi SS; Liu XJ; Hu RM; Miao Y; Huang GQ; Yang QP J Dermatol; 2015 Oct; 42(10):981-8. PubMed ID: 26077574 [TBL] [Abstract][Full Text] [Related]
35. The Role of Serum Th1, Th2, and Th17 Cytokines in Patients with Alopecia Areata: Clinical Implications. Waśkiel-Burnat A; Osińska M; Salińska A; Blicharz L; Goldust M; Olszewska M; Rudnicka L Cells; 2021 Dec; 10(12):. PubMed ID: 34943905 [TBL] [Abstract][Full Text] [Related]
36. Serum level of interleukin-17A in patients with alopecia areata and its relationship to age. El-Morsy EH; Eid AA; Ghoneim H; Al-Tameemi KA Int J Dermatol; 2016 Aug; 55(8):869-74. PubMed ID: 26475394 [TBL] [Abstract][Full Text] [Related]
37. Serum level of IL-4 predicts response to topical immunotherapy with diphenylcyclopropenone in alopecia areata. Gong Y; Zhao Y; Zhang X; Qi S; Li S; Ye Y; Yang J; Caulloo S; McElwee KJ; Zhang X Exp Dermatol; 2020 Mar; 29(3):231-238. PubMed ID: 30047620 [TBL] [Abstract][Full Text] [Related]
38. Evaluation of complete blood cell and inflammatory parameters in patients with alopecia areata: Their association with disease severity. İslamoğlu ZGK; Demirbaş A J Cosmet Dermatol; 2020 May; 19(5):1239-1245. PubMed ID: 31502748 [TBL] [Abstract][Full Text] [Related]
39. Alopecia Areata Is Associated with Atopic Diathesis: Results from a Population-Based Study of 51,561 Patients. Kridin K; Renert-Yuval Y; Guttman-Yassky E; Cohen AD J Allergy Clin Immunol Pract; 2020 Apr; 8(4):1323-1328.e1. PubMed ID: 32036002 [TBL] [Abstract][Full Text] [Related]
40. Study of Th1/Th2 balance in peripheral blood mononuclear cells of patients with alopecia areata. Sadeghi S; Sanati MH; Taghizadeh M; Mansouri P; Jadali Z Acta Microbiol Immunol Hung; 2015 Sep; 62(3):275-85. PubMed ID: 26551570 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]